Key result
In a 52-year-old man with hepatitis B-related cirrhosis, MRI follow-up over three months revealed a rapid progression of primary hepatic angiosarcoma from 5-6 mm nodules to an 8.5 cm lesion.
Why the study?
Primary hepatic angiosarcoma is a rare, aggressive tumour with non-specific presentation, and the authors aimed to highlight its MRI features and underline its rapid, fatal progression.
Case Report (n=1)
This case report highlights the rapid progression of primary hepatic angiosarcoma and its MRI features.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rapid progression risk in cirrhosis; leaves open optimal surveillance protocols for hepatic angiosarcoma.
Primary hepatic angiosarcoma (PHA) is a sporadic and aggressive tumour of the liver that originates from mesenchymal cells and represents less than 2% of all primary liver tumours. It is known to be associated with several environmental and industrial carcinogens; however, in 75% of cases, aetiology remains unclear. Patients generally present with nonspecific symptoms and laboratory findings. Imaging has a limited role in the diagnosis. We herein present a case of a 52-year-old man with a history of hepatitis B-related cirrhosis who was referred to our hospital for liver transplantation assessment. Magnetic resonance imaging (MRI) revealed two small nodular lesions of 5 and 6 mm in segment IV of the liver, categorised as Liver Imaging Reporting and Data System (LI-RADS) category 3. The patient was discussed at a multidisciplinary tumour meeting, and an MRI follow-up in three months was planned. Three months later, MRI depicted a substantial increase in the lesion size measured 8.5 cm. An ultrasound-guided tru-cut biopsy was performed, and the diagnosis of PHA was confirmed by pathology. In this report, we aim to highlight PHA's MRI features and underline this rare entity's rapid and fatal progression.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a case report in Primary hepatic angiosarcoma (n=1). Magnetic resonance imaging (MRI) was evaluated on Tumour progression and diagnosis. In a 52-year-old man with hepatitis B-related cirrhosis, MRI follow-up over three months revealed a rapid progression of primary hepatic angiosarcoma from 5-6 mm nodules to an 8.5 cm lesion.
Synapse has enriched 10 related papers. Consider them for comparative context: